Complementary and alternative medicine research: A National Cancer Institute perspective

被引：25
作者：
White, JD
机构：
[1] NCI, Off Canc Complementary & Alternat Med, NIH, Bethesda, MD 20892 USA
[2] NCI, Off Deputy Director Extramural Sci, NIH, Bethesda, MD 20892 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1053/sonc.2002.50003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The widespread use of a variety of nutritional, psychological and natural medical approaches, collectively termed complementary and alternative medicine (CAM), has been well documented. Recent surveys demonstrate that between 9% and 91% of US cancer patients use CAM therapies at some time after their diagnosis. Despite their extensive use, there is a paucity of data available to indicate whether these practices are efficacious and safe. The National Cancer Institute (NCI) is implementing programs to increase the amount and quality of cancer CAM research, support the production of high-quality CAM cancer information, and facilitate the dialog between CAM practitioners and cancer researchers.
引用
收藏
页码：546 / 551
页数：6
相关论文
共 26 条
  • [1] An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
    Ben-Shabat, S
    Fride, E
    Sheskin, T
    Tamiri, T
    Rhee, MH
    Vogel, Z
    Bisogno, T
    De Petrocellis, L
    Di Marzo, V
    Mechoulam, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (01) : 23 - 31
  • [2] Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma
    Buckner, JC
    Malkin, MG
    Reed, E
    Cascino, TL
    Reid, JM
    Ames, MM
    Tong, WPY
    Lim, S
    Figg, WD
    [J]. MAYO CLINIC PROCEEDINGS, 1999, 74 (02) : 137 - 145
  • [3] Burzynski SR, 1999, MAYO CLIN PROC, V74, P641, DOI 10.4065/74.6.641
  • [4] CHLEBOWSKI RT, 1987, CANCER, V59, P406, DOI 10.1002/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO
  • [5] 2-W
  • [6] FAILURE OF HIGH-DOSE VITAMIN-C (ASCORBIC-ACID) THERAPY TO BENEFIT PATIENTS WITH ADVANCED CANCER - CONTROLLED TRIAL
    CREAGAN, ET
    MOERTEL, CG
    OFALLON, JR
    SCHUTT, AJ
    OCONNELL, MJ
    RUBIN, J
    FRYTAK, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (13) : 687 - 690
  • [7] Ernst E, 1998, CANCER-AM CANCER SOC, V83, P777, DOI 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO
  • [8] 2-O
  • [9] Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support
    Gonzalez, NJ
    Isaacs, LL
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1999, 33 (02): : 117 - 124
  • [10] GONZALEZ NJ, 2000, TESTIMONY WHITE HOUS
123